✦ LIBER ✦

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)

✍ Scribed by Kazutomo Kinoshita; Kohsuke Asoh; Noriyuki Furuichi; Toshiya Ito; Hatsuo Kawada; Sousuke Hara; Jun Ohwada; Takuho Miyagi; Takamitsu Kobayashi; Kenji Takanashi; Toshiyuki Tsukaguchi; Hiroshi Sakamoto; Takuo Tsukuda; Nobuhiro Oikawa

Book ID: 113495645
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 624 KB
Volume: 20
Category: Article
ISSN: 0968-0896
DOI: 10.1016/j.bmc.2011.12.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Synthesis of Selective and Po

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

✍ Dr. Henri Mattes; Prof. Dr. Kumlesh Kumar Dev; Dr. Rochdi Bouhelal; Dr. Carmen B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

Synthesis and Pharmacological Characteri

Synthesis and Pharmacological Characterization of a Potent, Orally Active p38 Kinase Inhibitor (I).

✍ Jacques Dumas; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB

Corrigendum: Design and Synthesis of Sel

Corrigendum: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

✍ Dr. Henri Mattes; Prof. Dr. Kumlesh Kumar Dev; Dr. Rochdi Bouhelal; Dr. Carmen B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

Design and Synthesis of Potent, Selectiv

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

✍ Liverton, Nigel J.; Butcher, John W.; Claiborne, Christopher F.; Claremon, David 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 335 KB

Pharmacological profile of AW-814141, a

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

✍ Puneet Chopra; Onkar Kulkarni; Shashank Gupta; Malini Bajpai; Vijay Kanoje; Mani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 468 KB

ChemInform Abstract: Discovery of GSK143

ChemInform Abstract: Discovery of GSK143 (I), a Highly Potent, Selective and Orally Efficacious Spleen Tyrosine Kinase Inhibitor.

✍ John Liddle; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views